Association between pathological and MRI findings in multiple sclerosis

Massimo Filippi, Wolfgang Brück, Declan Chard, Franz Fazekas, Jeroen J. G. Geurts, Christian Enzinger, Simon Hametner, Tanja Kuhlmann, Paolo Preziosa, Àlex Rovira, Klaus Schmierer, Christine Stadelmann, Maria A. Rocca, Attendees of the Correlation between Pathological and MRI findings in MS workshop

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

Pathological evaluation is the gold standard for identifying processes related to multiple sclerosis that explain disease manifestations, and for guiding the development of new treatments. However, there are limitations to the techniques used, including the small number of donors available, samples often representing uncommon cases, and impossibility of follow-up. Correlative studies have demonstrated that MRI is sensitive to the different pathological substrates of multiple sclerosis (inflammation, demyelination, and neuro-axonal loss). The role of MRI in evaluating other pathological processes, such as leptomeningeal involvement, central vein and rim of lesions, microstructural abnormalities, iron accumulation, and recovery mechanisms, has been investigated. Although techniques used for quantifying pathological processes in different regions of the CNS have advanced diagnosis and monitoring of disease course and treatment of multiple sclerosis, new perspectives and questions have emerged, including how different pathological processes interact over the disease course and when remyelination might occur. Addressing these questions will require longitudinal studies using MRI in large cohorts of patients with different phenotypes.
Original languageEnglish
Pages (from-to)198-210
JournalThe Lancet Neurology
Volume18
Issue number2
DOIs
Publication statusPublished - 1 Feb 2019

Cite this

Filippi, M., Brück, W., Chard, D., Fazekas, F., Geurts, J. J. G., Enzinger, C., ... Attendees of the Correlation between Pathological and MRI findings in MS workshop (2019). Association between pathological and MRI findings in multiple sclerosis. The Lancet Neurology, 18(2), 198-210. https://doi.org/10.1016/S1474-4422(18)30451-4
Filippi, Massimo ; Brück, Wolfgang ; Chard, Declan ; Fazekas, Franz ; Geurts, Jeroen J. G. ; Enzinger, Christian ; Hametner, Simon ; Kuhlmann, Tanja ; Preziosa, Paolo ; Rovira, Àlex ; Schmierer, Klaus ; Stadelmann, Christine ; Rocca, Maria A. ; Attendees of the Correlation between Pathological and MRI findings in MS workshop. / Association between pathological and MRI findings in multiple sclerosis. In: The Lancet Neurology. 2019 ; Vol. 18, No. 2. pp. 198-210.
@article{40deaf2c859a47b2b3167d5c10fd550e,
title = "Association between pathological and MRI findings in multiple sclerosis",
abstract = "Pathological evaluation is the gold standard for identifying processes related to multiple sclerosis that explain disease manifestations, and for guiding the development of new treatments. However, there are limitations to the techniques used, including the small number of donors available, samples often representing uncommon cases, and impossibility of follow-up. Correlative studies have demonstrated that MRI is sensitive to the different pathological substrates of multiple sclerosis (inflammation, demyelination, and neuro-axonal loss). The role of MRI in evaluating other pathological processes, such as leptomeningeal involvement, central vein and rim of lesions, microstructural abnormalities, iron accumulation, and recovery mechanisms, has been investigated. Although techniques used for quantifying pathological processes in different regions of the CNS have advanced diagnosis and monitoring of disease course and treatment of multiple sclerosis, new perspectives and questions have emerged, including how different pathological processes interact over the disease course and when remyelination might occur. Addressing these questions will require longitudinal studies using MRI in large cohorts of patients with different phenotypes.",
author = "Massimo Filippi and Wolfgang Br{\"u}ck and Declan Chard and Franz Fazekas and Geurts, {Jeroen J. G.} and Christian Enzinger and Simon Hametner and Tanja Kuhlmann and Paolo Preziosa and {\`A}lex Rovira and Klaus Schmierer and Christine Stadelmann and Rocca, {Maria A.} and {Attendees of the Correlation between Pathological and MRI findings in MS workshop}",
year = "2019",
month = "2",
day = "1",
doi = "10.1016/S1474-4422(18)30451-4",
language = "English",
volume = "18",
pages = "198--210",
journal = "Lancet Neurology",
issn = "1474-4422",
publisher = "Lancet Publishing Group",
number = "2",

}

Filippi, M, Brück, W, Chard, D, Fazekas, F, Geurts, JJG, Enzinger, C, Hametner, S, Kuhlmann, T, Preziosa, P, Rovira, À, Schmierer, K, Stadelmann, C, Rocca, MA & Attendees of the Correlation between Pathological and MRI findings in MS workshop 2019, 'Association between pathological and MRI findings in multiple sclerosis' The Lancet Neurology, vol. 18, no. 2, pp. 198-210. https://doi.org/10.1016/S1474-4422(18)30451-4

Association between pathological and MRI findings in multiple sclerosis. / Filippi, Massimo; Brück, Wolfgang; Chard, Declan; Fazekas, Franz; Geurts, Jeroen J. G.; Enzinger, Christian; Hametner, Simon; Kuhlmann, Tanja; Preziosa, Paolo; Rovira, Àlex; Schmierer, Klaus; Stadelmann, Christine; Rocca, Maria A.; Attendees of the Correlation between Pathological and MRI findings in MS workshop.

In: The Lancet Neurology, Vol. 18, No. 2, 01.02.2019, p. 198-210.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - Association between pathological and MRI findings in multiple sclerosis

AU - Filippi, Massimo

AU - Brück, Wolfgang

AU - Chard, Declan

AU - Fazekas, Franz

AU - Geurts, Jeroen J. G.

AU - Enzinger, Christian

AU - Hametner, Simon

AU - Kuhlmann, Tanja

AU - Preziosa, Paolo

AU - Rovira, Àlex

AU - Schmierer, Klaus

AU - Stadelmann, Christine

AU - Rocca, Maria A.

AU - Attendees of the Correlation between Pathological and MRI findings in MS workshop

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Pathological evaluation is the gold standard for identifying processes related to multiple sclerosis that explain disease manifestations, and for guiding the development of new treatments. However, there are limitations to the techniques used, including the small number of donors available, samples often representing uncommon cases, and impossibility of follow-up. Correlative studies have demonstrated that MRI is sensitive to the different pathological substrates of multiple sclerosis (inflammation, demyelination, and neuro-axonal loss). The role of MRI in evaluating other pathological processes, such as leptomeningeal involvement, central vein and rim of lesions, microstructural abnormalities, iron accumulation, and recovery mechanisms, has been investigated. Although techniques used for quantifying pathological processes in different regions of the CNS have advanced diagnosis and monitoring of disease course and treatment of multiple sclerosis, new perspectives and questions have emerged, including how different pathological processes interact over the disease course and when remyelination might occur. Addressing these questions will require longitudinal studies using MRI in large cohorts of patients with different phenotypes.

AB - Pathological evaluation is the gold standard for identifying processes related to multiple sclerosis that explain disease manifestations, and for guiding the development of new treatments. However, there are limitations to the techniques used, including the small number of donors available, samples often representing uncommon cases, and impossibility of follow-up. Correlative studies have demonstrated that MRI is sensitive to the different pathological substrates of multiple sclerosis (inflammation, demyelination, and neuro-axonal loss). The role of MRI in evaluating other pathological processes, such as leptomeningeal involvement, central vein and rim of lesions, microstructural abnormalities, iron accumulation, and recovery mechanisms, has been investigated. Although techniques used for quantifying pathological processes in different regions of the CNS have advanced diagnosis and monitoring of disease course and treatment of multiple sclerosis, new perspectives and questions have emerged, including how different pathological processes interact over the disease course and when remyelination might occur. Addressing these questions will require longitudinal studies using MRI in large cohorts of patients with different phenotypes.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85060030193&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/30663609

U2 - 10.1016/S1474-4422(18)30451-4

DO - 10.1016/S1474-4422(18)30451-4

M3 - Review article

VL - 18

SP - 198

EP - 210

JO - Lancet Neurology

JF - Lancet Neurology

SN - 1474-4422

IS - 2

ER -